Bloomberg -- Pfizer Inc. (PFE), the world’s biggest drugmaker, told a federal jury that it lost billions of dollars in sales from unauthorized copies of the epilepsy drug Neurontin and it wants the money back. Pfizer claims copies of the pill made by Teva Pharmaceutical Industries Ltd. (TEVA) and its Ivax unit, along with Actavis Group hf’s Purepac unit, infringe a patent that expires in 2017. During opening statements today in federal court in Newark, New Jersey, the generic-drug makers rejected the claim and told jurors that the brand drug only became a blockbuster for Pfizer because of the company’s illegal marketing activity.
